GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hanall Biopharma Co Ltd (XKRX:009420) » Definitions » Other Current Liabilities

Hanall Biopharma Co (XKRX:009420) Other Current Liabilities

: ₩16,558 Mil (As of Dec. 2023)
View and export this data going back to 1989. Start your Free Trial

Hanall Biopharma Co's other current liabilities for the quarter that ended in Dec. 2023 was ₩16,558 Mil.

Hanall Biopharma Co's quarterly other current liabilities increased from Jun. 2023 (₩15,769 Mil) to Sep. 2023 (₩16,130 Mil) and increased from Sep. 2023 (₩16,130 Mil) to Dec. 2023 (₩16,558 Mil).

Hanall Biopharma Co's annual other current liabilities increased from Dec. 2021 (₩13,443 Mil) to Dec. 2022 (₩13,813 Mil) and increased from Dec. 2022 (₩13,813 Mil) to Dec. 2023 (₩16,558 Mil).


Hanall Biopharma Co Other Current Liabilities Historical Data

The historical data trend for Hanall Biopharma Co's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hanall Biopharma Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Liabilities
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Hanall Biopharma Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Other Current Liabilities Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Hanall Biopharma Co Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.


Hanall Biopharma Co Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Hanall Biopharma Co's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Hanall Biopharma Co (XKRX:009420) Business Description

Traded in Other Exchanges
N/A
Address
12 Bongeunsa-ro 114-gil, Daewoong Building, 3rd Floor, Gangnam-gu, Seoul, KOR
Hanall Biopharma Co Ltd is a part of the healthcare sector. It is one of Korea's leading pharmaceutical companies and is focused on drug delivery, biotherapeutics, and new small molecule discovery. The company's scope comprises of ophthalmology, immunology, cardiovascular treatment and dermatology.

Hanall Biopharma Co (XKRX:009420) Headlines

No Headlines